2005•Chinese Remedies & ClinicsRequires access

Experimental study on treatment of nonalcoholic fatty liver disease by compound herbs

Fengxia Li

Open publisher page 1 citations

Abstract

Objective To investigate the effect of compound herbs in nonalcoholic fatty liver disease. Methods Fatty liver animal model was duplicated with high fat diet,and divided into model group,herbs high dose group,herbs low dose group,gemfibrozil group and normal control group randomly.Each treatment group was intervened by its own medicine.Then the contents of total cholesterol(TC),triglycerides (TG),free fatty acid(FFA) in serum,the contents of TC,TG,FFA and the expression of acyl-CoA oxidase(AOX) in hepatic tissue were detected,evaluating the levels of steatosis and steatohepatitis in liver. Results Compared with the model group(7.33±0.42,1.49±0.06,888.23±56.15,244.75± 30.27,108.78±6.95,166.54±6.54),the content of serum lipid and liver lipid in herbs high dose group(2.46±0.10,0.63±0.06,279.01±13.43,89.82±2.78,53.22±2.39,97.30±9.91) were reduced remarkably(q=45.18,38.39,51.73,29.63,29.46,P0.05).The severity degrees of steatosis and steatohepatitis were significantly lower in herbs high dose group and gemfibrozil group than those in model group(P0.05).The expression of AOX was higher in herbs high dose group and gemfibrozil group than in model group(q=8.46,4.04,P0.05). Conclusion The compound herbs is effective in treating nonalcoholic fatty liver disease.

About this research paper

What this paper is about

Objective To investigate the effect of compound herbs in nonalcoholic fatty liver disease. Methods Fatty liver animal model was duplicated with high fat diet,and divided into model group,herbs high dose group,herbs low dose group,gemfibrozil group and normal control group randomly.Each treatment group was intervened by its own medicine.Then the contents of total cholesterol(TC),triglycerides (TG),free fatty acid(FFA) in serum,the contents of TC,TG,FFA and the expression of acyl-CoA oxidase(AOX) in hepatic tissue were detected,evaluating the levels of steatosis and steatohepatitis in liver. Results Compared with the model group(7.33±0.42,1.49±0.06,888.23±56.15,244.75± 30.27,108.78±6.95,166.54±6.54),the content of serum lipid and liver lipid in herbs high dose group(2.46±0.10,0.63±0.06,279.01±13.43,89.82±2.78,53.22±2.39,97.30±9.91) were reduced remarkably(q=45.18,38.39,51.73,29.63,29.46,P0.05).The severity degrees of steatosis and steatohepatitis were significantly lower in herbs high dose group and gemfibrozil group than those in model group(P0.05).The expression of AOX was higher in herbs high dose group and gemfibrozil group than in model group(q=8.46,4.04,P0.05). Conclusion The compound herbs is effective in treating nonalcoholic fatty liver disease.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the effect of compound herbs in nonalcoholic fatty liver disease. Methods Fatty liver animal model was duplicated with high fat diet,and divided into model group,herbs high dose group,herbs low dose group,gemfibrozil group and normal control group randomly.Each treatment group was intervened by its own medicine.Then the contents of total cholesterol(TC),triglycerides (TG),free fatty acid(FFA) in serum,the contents of TC,TG,FFA and the expression of acyl-CoA oxidase(AOX) in hepatic tissue were detected,evaluating the levels of steatosis and steatohepatitis in liver. Results Compared with the model group(7.33±0.42,1.49±0.06,888.23±56.15,244.75± 30.27,108.78±6.95,166.54±6.54),the content of serum lipid and liver lipid in herbs high dose group(2.46±0.10,0.63±0.06,279.01±13.43,89.82±2.78,53.22±2.39,97.30±9.91) were reduced remarkably(q=45.18,38.39,51.73,29.63,29.46,P0.05).The severity degrees of steatosis and steatohepatitis were significantly lower in herbs high dose group and gemfibrozil group than those in model group(P0.05).The expression of AOX was higher in herbs high dose group and gemfibrozil group than in model group(q=8.46,4.04,P0.05). Conclusion The compound herbs is effective in treating nonalcoholic fatty liver disease.

Key concepts: Gemfibrozil, Nonalcoholic fatty liver disease, Steatosis, Internal medicine, Medicine, Fatty liver, Gastroenterology, Sesamin

Related papers

Back to paper searchBrowse research topicsOriginal source
Experimental study on treatment of nonalcoholic fatty liver disease by compound herbs — Research Paper | ScholarLens